Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -107.89x is 52% above its 1-year average of -223.01x, near the high end of its 1-year range (-866.26x–-21.20x).
51.62% above its 12-month average of -223.01x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2026 (2026-06-30): -21.20x.
INTEREST COVERAGE RATIO
-107.89x
INTEREST COVERAGE RATIO AVG TTM
-223.01x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+51.62%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-1592.39%
vs the sector median at left
Citius Oncology, Inc.
Market Cap
$77.80M
Interest Coverage Ratio
-107.89x
TTM Avg
-223.01x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$75.39M
Interest Coverage Ratio
-17.01x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$76.54M
Interest Coverage Ratio
-1.08x
TTM Avg
0.90x
3Y Avg
0.90x
5Y Avg
0.90x
Market Cap
$77.28M
Interest Coverage Ratio
-23.23x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$77.15M
Interest Coverage Ratio
-4056.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$77.57M
Interest Coverage Ratio
-4.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$78.42M
Interest Coverage Ratio
N/A
TTM Avg
273.61x
3Y Avg
273.61x
5Y Avg
273.61x
Market Cap
$72.60M
Interest Coverage Ratio
N/A
TTM Avg
933.58x
3Y Avg
933.58x
5Y Avg
933.58x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Citius Oncology, Inc. (CTOR) | $77.80M | -107.89x | -223.01x | N/A | N/A |
| Pulmonx Corporation (LUNG)vs › | $75.39M | -17.01x | N/A | N/A | N/A |
| SkinHealth Systems Inc. (SKIN)vs › | $76.54M | -1.08x | 0.90x | 0.90x | 0.90x |
| Hyperfine, Inc. (HYPR)vs › | $74.53M | N/A | N/A | N/A | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.28M | -23.23x | N/A | N/A | N/A |
| Sera Prognostics, Inc. (SERA)vs › | $77.15M | -4056.00x | N/A | N/A | N/A |
| Outset Medical, Inc. (OM)vs › | $77.57M | -4.78x | N/A | N/A | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.42M | N/A | 273.61x | 273.61x | 273.61x |
| MindWalk Holdings Corp. (HYFT)vs › | $72.60M | N/A | 933.58x | 933.58x | 933.58x |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $72.83M | -1.54x | N/A | N/A | N/A |
Interest Coverage
-107.9x
Debt/Equity
0.25
Current Ratio
0.73
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -21.20x |
| 2026-03-31 | -866.26x |
| 2025-12-31 | -114.58x |
| 2025-09-30 | -82.26x |
| 2025-06-30 | -30.76x |
